MEIS1 and acute myeloid leukemia: Similar to what was found in t(8;21) AMLs, PRMT1 physically associates with these leukemic fusion oncoproteins and is required for high expression of their target genes such as HOX and MEIS1, supporting targeting PRMT1 as new AML therapeutics.